As of Aug 03
| -0.16 / -2.62%|
The 6 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +34.45% increase from the last price of 5.95.
The current consensus among 6 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.